Multiple Sclerosis and MEN2 Neoplasia in a Female Patient: A Unique Co-Existence with Expanded Immunological Interest and Therapeutical Challenges, before and after Patient’s COVID-19 Infection
Nikolaos Markoglou(National and Kapodistrian University of Athens), Maria Anagnostouli(National and Kapodistrian University of Athens), Maria Alevizaki(National and Kapodistrian University of Athens), George Simeakis(404 General Military Hospital), Georgios Velonakis(National and Kapodistrian University of Athens), Maria Spyropoulou‐Vlachou(Academy of Athens), Leonidas Stefanis(National and Kapodistrian University of Athens), Catherine Stavropoulos‐Giokas(Academy of Athens), Theofanis Chatzistamatiou(Academy of Athens)
Cited by 0
Related Papers
-Synuclein in Parkinson's Disease
|Cold Spring Harbor Perspectives in Medicine|2011|1.4k
Wild Type α-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
|Journal of Biological Chemistry|2008|664
Studies of insulin resistance in patients with clinical and subclinical hypothyroidism
|European Journal of Endocrinology|2009|459
Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case–control study
|The Lancet Neurology|2011|344